Category: Top Story
-
Five key themes for markets in the week ahead
The ongoing conflict involving Iran is expected to remain the main focus for investors in the coming days, as markets assess the potential consequences for energy prices and global assets. A preliminary reading of U.S. business activity could offer early insight into how the conflict is affecting the broader economy, while cruise operator Carnival Corp.…
-
Nvidia could modify Feynman AI platform amid TSMC capacity constraints – report
Nvidia (NASDAQ:NVDA) may be forced to adjust the design of its upcoming Feynman artificial intelligence platform because of limited manufacturing capacity at Taiwan Semiconductor Manufacturing Co. (NYSE:TSM), according to a report published Monday by Taiwan’s Economic Daily News. The report said demand for TSMC’s cutting-edge 2-nanometer chip production has surged, driven by major AI companies…
-
Musk says SpaceX and Tesla to develop advanced chip plants in Austin
Elon Musk said on Sunday that SpaceX and Tesla (NASDAQ:TSLA) plan to construct two advanced semiconductor manufacturing plants at a large new facility in Austin, Texas — one focused on powering vehicles and humanoid robots, and another aimed at supplying artificial intelligence data centers operating in space. The remarks came a day after Musk unveiled…
-
Gold miners slide as bullion deepens losses on rising rate expectations
Shares of major gold mining companies fell sharply on Monday as gold prices dropped to their lowest level in four months, extending a steep decline from last week as geopolitical tensions and inflation concerns push investors to reassess the outlook for global interest rates. Leading producers including Newmont (NYSE:NEM), Barrick (NYSE:B), Agnico Eagle (NYSE:AEM) and…
-
Trump issues Iran ultimatum; IEA warns of “severe” oil crisis — what’s driving markets: Dow Jones, S&P, Nasdaq, Wall Street Futures
Futures tied to major U.S. stock indices moved lower Monday as the conflict with Iran continues, raising concerns about a prolonged surge in global energy prices. U.S. President Donald Trump has given Iran until Monday night to reopen the Strait of Hormuz, an ultimatum Tehran has rejected. Meanwhile, the International Energy Agency cautioned that the…
-
Guardian Metal Marks Major Milestone with U.S. Market Debut
Guardian Metal Resources plc (AMEX:GMTL) has taken a significant step in its growth journey, celebrating its debut on the NYSE American, a move that signals both increased ambition and rising relevance in the global critical minerals sector. The company, which focuses on tungsten exploration in the United States, began trading under the ticker “GMTL,” marking…
-
Wall Street Reeling as Quadruple Witching and War Risks Trigger Tech Sell-Off
U.S. equities plummeted on Friday as a perfect storm of “Quadruple Witching” volatility, escalating conflict in the Middle East, and a federal crackdown on semiconductor smuggling sent shockwaves through the market. A record-breaking $5.7 trillion in options expirations amplified the day’s swings, while reports of U.S. military preparations to reopen the Strait of Hormuz drove…
-
Wall Street faces renewed downside amid oil swings and geopolitical risks: Dow Jones, S&P and Nasdaq Futures
Dow Jones, S&P 500 and Nasdaq futures are currently pointing to a lower open on Friday, with stocks likely to see further downside after recovering from their worst levels but still ending the previous session modestly lower. The downward momentum on Wall Street comes amid considerable volatility by the price of crude oil, which has…
-
Wall Street Slide Continues as Oil Volatility and Fed Caution Weigh on Sentiment
U.S. markets extended their downward trend on Thursday as investors grappled with a “double whammy” of geopolitical instability and a recalibrated interest rate outlook. While indices managed to pare some of their steeper intraday losses following diplomatic efforts to stabilize energy corridors, the major averages ultimately finished in the red for a second consecutive session.…
-
Pfizer’s TALZENNA combination shows progress against prostate cancer
Pfizer Inc. (NYSE:PFE) announced that its Phase 3 TALAPRO-3 clinical trial met its primary endpoint, demonstrating that the combination of TALZENNA (talazoparib) and XTANDI (enzalutamide) significantly improved radiographic progression-free survival compared with placebo plus XTANDI in patients with homologous recombination repair (HRR) gene–mutated metastatic castration-sensitive prostate cancer. The global study enrolled 599 patients across the…